Growth alterations in rare forms of primary adrenal insufficiency: a neglected issue in paediatric endocrinology
- PMID: 36309634
- DOI: 10.1007/s12020-022-03236-z
Growth alterations in rare forms of primary adrenal insufficiency: a neglected issue in paediatric endocrinology
Abstract
Primary adrenal insufficiency (PAI) is an endocrine disorder characterized by direct adrenal failure, with consequent glucocorticoid, and eventually mineralocorticoid, deficiency. In children, the main cause of PAI is congenital adrenal hyperplasia (CAH), due to a loss of function of adrenal steroidogenic enzymes, but also rarer forms, including autoimmune polyglandular syndrome, adrenoleucodistrophy, adrenal hypoplasia congenita, familial glucocorticoid deficiency, and Allgrove's Syndrome, may be observed. In PAI children, growth alterations represent a major issue, as both inadequate and excessive glucocorticoid replacement treatment may lead to reduced growth rate and adult height impairment. However, growth abnormalities are poorly studied in rare forms of paediatric PAI, and specific studies on growth rate in these children are currently lacking. In the present review, the currently available evidence on growth alterations in children with rare PAI forms will be summarized, with a major focus on comorbidities with a potential impact on patients' growth rate.
Keywords: Adrenal insufficiency; Children; Growth; Growth rate; Height; Primay adrenal insufficiency.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Rare forms of genetic paediatric adrenal insufficiency: Excluding congenital adrenal hyperplasia.Rev Endocr Metab Disord. 2023 Apr;24(2):345-363. doi: 10.1007/s11154-023-09784-7. Epub 2023 Feb 10. Rev Endocr Metab Disord. 2023. PMID: 36763264 Free PMC article. Review.
-
Etiology of primary adrenal insufficiency in children: a 29-year single-center experience.J Pediatr Endocrinol Metab. 2019 Jun 26;32(6):615-622. doi: 10.1515/jpem-2018-0445. J Pediatr Endocrinol Metab. 2019. PMID: 31141483 Clinical Trial.
-
Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia.Arch Endocrinol Metab. 2021 Nov 3;65(4):488-494. doi: 10.20945/2359-3997000000392. Epub 2021 Jul 16. Arch Endocrinol Metab. 2021. PMID: 34283908 Free PMC article. Review.
-
Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology.Front Immunol. 2023 Nov 15;14:1275828. doi: 10.3389/fimmu.2023.1275828. eCollection 2023. Front Immunol. 2023. PMID: 38045693 Free PMC article.
-
Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.Cochrane Database Syst Rev. 2020 Mar 19;3(3):CD012517. doi: 10.1002/14651858.CD012517.pub2. Cochrane Database Syst Rev. 2020. PMID: 32190901 Free PMC article.
References
-
- T. Kirkgoz, T. Guran, Primary adrenal insufficiency in children: Diagnosis and management. Best. Pr. Res Clin. Endocrinol. Metab. 32(4), 397–424 (2018) - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical